DEFA14A ·Filed Mar 12, 2026

NEU

NEWMARKET CORP
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-102977
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard, non-material filing. Traders should note the upcoming shareholder meeting date but no immediate action is required based on this document.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
NEU ▲ +35.05% at T+60d
NEUTRAL call ✓ call won +35.05% · α vs SPY +24.35% · entry $585.06 → $790.13
Entry anchored
Mar 12, 04:29 AM ET
via exchange tick
T+1d
-0.58%
call -0.58% · α +0.02%
$581.66
settled 7mo ago
T+5d
+3.81%
call +3.81% · α +4.79%
$607.37
settled 7mo ago
T+20d
+7.47%
call +7.47% · α +5.49%
$628.74
settled 6mo ago
T+60d
+35.05%
call +35.05% · α +24.35%
$790.13
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

NewMarket Corp (NEU) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Shareholders, scheduled for April 23, 2026. The filing is routine and outlines the standard agenda for the annual shareholder vote, including the election of seven director nominees, the ratification of PwC as the independent auditor, and an advisory vote on executive compensation.

Key Facts

  • The filing is a routine DEFA14A proxy statement for the 2026 Annual Meeting.
  • The meeting will be held on April 23, 2026, in Richmond, VA.
  • Proposals include the election of 7 director nominees, ratification of PwC as auditors, and an advisory vote on executive pay.
  • The Board of Directors recommends a vote FOR all nominees and proposals.
  • The document is for informational and voting purposes only, with no new financial data or material announcements.

Financial Impact

None. This is an administrative filing with no direct financial impact.

Risk Factors

  • None identified from this filing.

Market Snapshot

Exchange
NYSE

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-102977
Document: 0001193125-26-102977-index-headers.html0001193125-26-102977
Document: 0001193125-26-102977-index.html0001193125-26-102977
Document: 0001193125-26-102977.txt0001193125-26-102977
3 reports for NEU
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NEU — sortable, filterable
TypeNow
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$961.92 $880.52▼ −8.46%▼ −6.47%$927.95 (−3.53%)
Apr 22, 2026
23w ago
8-K
BEARISH ★ 6/10
$683.04 $708.32▼ −3.70%▲ +0.93%$927.95 (−35.86%)
Mar 12, 2026
29w ago
DEFA14A
NEUTRAL ★ 3/10
$585.06 $628.74▲ +7.47%▲ +5.49%$927.95 (+58.61%)
Showing 3 of 3

US Market Status

Market Open — Closes in 3h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access